These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary excretion of plasma proteins in diabetic subjects. Increased excretion of kappa light chains in diabetic patients with and without proliferative retinopathy. Teppo AM, Groop L. Diabetes; 1985 Jun; 34(6):589-94. PubMed ID: 3924692 [Abstract] [Full Text] [Related]
3. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias. Levinson SS. Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799 [Abstract] [Full Text] [Related]
4. Prognostic value of urinary protein in primary systemic amyloidosis (AL). Gertz MA, Kyle RA. Am J Clin Pathol; 1990 Sep; 94(3):313-7. PubMed ID: 2118721 [Abstract] [Full Text] [Related]
6. Urinary excretion of ten plasma proteins in patients with febrile diseases. Hemmingsen L, Skaarup P. Acta Med Scand; 1977 Sep; 201(4):359-64. PubMed ID: 403746 [Abstract] [Full Text] [Related]
7. Urinary excretion of ten plasma proteins in patients with renal carcinoma. Hemmingsen L, Skaarup P. Scand J Urol Nephrol; 1977 Sep; 11(1):41-6. PubMed ID: 403598 [Abstract] [Full Text] [Related]
11. Adult Fanconi syndrome in primary amyloidosis with lambda light-chain proteinuria. Rikitake O, Sakemi T, Yoshikawa Y, Nagano Y, Watanabe T. Jpn J Med; 1989 Sep; 28(4):523-6. PubMed ID: 2509772 [Abstract] [Full Text] [Related]
12. Immunofixation electrophoresis was highly specific for the diagnosis of renal light-chain amyloidosis. Zhou FD, Zhang LX, Yao Y, Wang SX, Zou WZ, Liu G, Chen M, Zhao MH. Am J Med Sci; 2013 Jan; 345(1):18-21. PubMed ID: 22627261 [Abstract] [Full Text] [Related]
13. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy. Silver MM, Hearn SA, Walton JC, Lines LA, Walley VM. Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473 [Abstract] [Full Text] [Related]
15. Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. Palladini G, Russo P, Bosoni T, Verga L, Sarais G, Lavatelli F, Nuvolone M, Obici L, Casarini S, Donadei S, Albertini R, Righetti G, Marini M, Graziani MS, Melzi D'Eril GV, Moratti R, Merlini G. Clin Chem; 2009 Mar; 55(3):499-504. PubMed ID: 19131635 [Abstract] [Full Text] [Related]
16. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR. Ann Intern Med; 1990 Mar 15; 112(6):455-64. PubMed ID: 2106817 [Abstract] [Full Text] [Related]